PILL CONNECT by Elucid mHealth
ABOUT THIS PRODUCT...
Elucid mHealth has developed a smart pill dispensing solution called Pill Connect which allows both clinical trial investigators and doctors to effectively monitor medication adherence, either in clinical trials or in the community.
Elucid is already in discussions with several top-tier Pharmas, CROs, CMOs, and the NHS, all of whom are keen to find effective ways to monitor patient adherence.
The system works through an app from the patient’s mobile phone (iPhone or android) which contains the pill regime – e.g. twice a day. The patient is trained on how to use the app, which takes around 20 minutes, and then given a Pill Connect bottle loaded with pills
The patient receives a reminder to take a pill via the app at a particular time. The patient responds to the reminder and a pill is dispensed and the data sent to a control centre.
If the patient does not respond, a text or call can be made automatically or manually to prompt adherence.
Elucid mHealth is a Manchester-based health technology company developing smart solutions to improve patient care. Pill Connect, Elucid’s smart dispensing system which aims to improve and monitor patient adherence, concluded its first clinical trials in 2019.
www.elucid-mhealth.com
The system means that the doctor or administrator has access to comprehensive data on each patient’s dispensing pattern.
The bottle is locked outside of the prescribed times to prevent double- dosing.
The Pill Connect dispenser mechanism and electronics are designed to fit onto a standard pill bottle, which is easily filled or refilled by a pharmacist. The capacity of the pill bottle will depend upon the pill size but will contain a minimum of 30 pills. The dispensing mechanism can be adjusted to handle pill/capsules of different sizes.
Company Contact
info@elucid-mhealth.com
www.elucid-mhealth.com 24 AWARDS 2020 CLICK HERE to vote for your favourite...
https://www.surveymonkey.co.uk/r/5BN
The Pill Connect system has now successfully completed two robustness clinical trials and has been granted two US patents. Elucid is continuing to work closely with The Medication Adherence Expertise Center at the University of Groningen in the Netherlands on further trials as well as trials with the NHS.
VOTE NOW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32
